Free CME from PeerView


Oncology CME

Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Translating Progress With Immunotherapies and Targeted Agents Into Improved Outcomes in Triple-Negative Breast Cancer: Surgical and Clinical Perspectives on Modern Multimodal Treatment Approaches
March 12, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Linking Immunotherapy to Better Outcomes in Resectable Melanoma: Guidance on Integrating Immune-Based Adjuvant and Neoadjuvant Options
March 10, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Modern Management of ITP: Thinking Beyond the Conventional Therapies
March 08, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Help Break the Stalled Cycle of Poor Outcomes?
February 22, 2022
Pasi A. Janne, MD, PhD
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing Key Targets in Advanced NSCLC: Evaluating the Latest Evidence and Clinical Opportunities for HER2-, HER3-, and TROP2-Targeted Therapies
February 22, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults
February 19, 2022
Stephen V. Liu, MD
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Visual Exploration of the Possibilities for Macrocyclic TKIs in Treatment-Naive and Pretreated Fusion-Positive NSCLC and Other Tumors
February 18, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Achieving State-of-the-Art Care in Bladder Cancer in an Era of Innovative Therapeutic Solutions
February 18, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
The Rising Tide of Novel BTK Inhibitors: Case-Based Guidance on Overcoming Intolerance, Resistance, and Other Clinical Challenges in B-Cell Cancers
February 17, 2022
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Mapping the Optimal Treatment Route in HCC: Identifying Best Practices in an Expanding Therapeutic Landscape
February 15, 2022
Boris Sepesi, MD, Tina Cascone, MD, PhD
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Bringing Precision Oncology to Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way: What Thoracic Surgeons Need to Know and Do
January 31, 2022
William D. Tap, MD
Credits: 0.25 CME / MOC
Medical Learning Institute, Inc.
Practice Points in TGCT: Updates on Safe Use of Novel Systemic Options
January 13, 2022
Michael Heinrich, MD
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Optimally Sequencing Modern TKIs in GIST: Expert Perspectives From an Interprofessional Sarcoma Team
January 13, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Upstream and Downstream Targeting of the Complement Pathway to Manage PNH: Current and Emerging Inhibitors
December 31, 2021
Bradley S. Miller, MD, PhD
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
December 30, 2021
John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
Credits: 2.0 CME
Penn State College of Medicine
Achieving Innovation in CLL Care: Evidence-Informed Choices With Targeted Options and Next Steps in Disease Management
December 30, 2021
Credits: 0.5 CME / MOC / CC / NCPD / CPE
Medical Learning Institute, Inc.
New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer: Practical Strategies for Optimal Clinical Integration of Adjuvant CDK4 and 6 Inhibitor Therapy
December 28, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
A Is for Antibody in Multiple Myeloma: Practical Insights and Patient Voices Along the Therapeutic Journey
December 10, 2021
Credits: 2 CME / MOC
Medical Learning Institute, Inc.
Seizing Opportunity in AML: How to Realize the Potential of Novel Therapeutics in Diverse Patient Populations
December 10, 2021
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Taking the Turn to Treatment Innovation in DLBCL: Real-World Insight on Integrating Antibodies and Cellular Therapy Into Patient Care
December 10, 2021
Credits: 1.5 CME
Medical Learning Institute, Inc.
A Better Blend for Follicular Lymphoma: How Targeted, Epigenetic, and Immune Therapies Are Changing Patient Care
December 10, 2021
John C. Byrd, MD
Credits: 1.5 CME / MOC
Medical Learning Institute, Inc.
Customizing Care in CLL With BTK Inhibitors: Evidence and Applications for Therapy Selection, Sequencing, and Safety Management
December 10, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Personalizing and Advancing Modern Treatment Approaches to Prostate Cancer
December 01, 2021

Pages